Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.
The Scientist
Most Recent
By discouraging change, universities are stunting scientific innovation, leadership, and growth.
A lack of methodological detail in the published literature threatens the foundation of scientific discourse.
More collaborators and more data are the key ingredients.
A US Fish and Wildlife official responds to the assertion that the northern spotted owl is being mismanaged by government.
With 12 new tuberculosis vaccines in clinical development, a plan is needed to introduce the most effective ones throughout the world.
Introducing DELSA Global, a community initiative to connect experts, share data, and democratize science.
The pitfalls of using public meetings as surrogate gauges of public opinion
Herd immunity, or the protection of individuals who are not vaccinated due to generally high vaccination rates within a population, does not currently exist in many pockets of the US.
The imperiled northern spotted owl faces extinction if efforts enacted to save it continue to put politics ahead of science.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
